AGP Picks
View all

Ecosense® Consumer Radon Monitoring Products Now Eligible for FSA and HSA Spending

Ecosense® has announced that its consumer radon monitors are now available for purchase using Health Savings Accounts

SILICON VALLEY, CA, UNITED STATES, October 1, 2026 /EINPresswire.com/ -- Ecosense®, a leading global innovator in radon detection and monitoring technology, has announced that its consumer radon monitors are now available for purchase using Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs), allowing consumers to buy their award-winning products using pre-tax dollars.

Radon is the leading cause of lung cancer among those individuals who do not smoke and contributes to an estimated 21,000 deaths every year in the US. Radon is an invisible and odorless radioactive gas; therefore, testing and continuous monitoring are needed to detect possible exposure in homes, businesses, and other indoor areas.

With FSA and HSA eligibility, consumers can use eligible account funds to purchase Ecosense®’s consumer radon monitoring solutions, including the award-winning EcoQube® and EcoQube Flex™. This initiative gives consumers another way to integrate radon awareness and monitoring into their broader approach to maintaining a healthy indoor environment.

“Radon exposure is a dangerous yet often overlooked health hazard since it cannot be seen, smelled, or tasted,” said Insoo Park, Founder and CEO of Ecosense®. “By making our consumer-grade products qualified for FSA and HSA spending, we can give more families the chance to adopt a more proactive approach in understanding the air quality of their homes. Having access to real-time radon data from continuous monitoring is the first step to limiting unnecessary exposure and reducing the risk of radon-related lung cancer, and making our home radon monitors eligible for FSA/HSA is a great opportunity to highlight how serious an issue radon is to insurance companies and the government.”

The technology Ecosense® uses in its consumer-grade products allows people to obtain real-time radon data about the environment inside their homes. Unlike traditional short-term radon test kits that provide a single result received by mail after lab analysis following a defined testing period, Ecosense®’s technology tracks radon levels over time, providing greater visibility into fluctuations while helping homeowners identify potential exposure concerns, understand the meaning of their radon levels, and decide on whether any action needs to be taken to reduce their radon exposure.

Consumers who plan to use FSA or HSA accounts on the Ecosense website are encouraged to check with their plan administrators for any requirements, as these can vary by plan. According to Truemed, eligible customers can save up to 30% using HSA/FSA funds.

For all media inquiries, please contact Thomas Mustac, Senior Publicist at Otter PR, at thomas.mustac@otterpr.com. To learn more about Ecosense®’s radon detection and monitoring solutions, visit www.ecosense.io.

About Ecosense®
Based in Silicon Valley, Ecosense® is a leader in smart radon detection technology, providing accurate, real-time monitoring solutions for professionals and consumers alike. Its patented ion chamber technology, validated by the University of Michigan and Kansas State University Radon Chamber, delivers research-grade accuracy in minutes, not days. Ecosense®’s innovations, including the C-NRPP-approved RadonEye and EcoQube® (named one of TIME’s 100 Best Inventions of 2021), EcoBlu™, and EcoQube Flex™, continue to redefine standards for health-focused environmental sensing worldwide.

Thomas Mustac
Otter PR
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.